Bevacizumab Effect on Blood Velocity
Completed
- Conditions
- Choroidal Neovascularization
- Registration Number
- NCT01298440
- Lead Sponsor
- Optical Imaging, Ltd.
- Brief Summary
Retinal blood flow velocity is affected by Bevacizump intravitreal injection. This effect is correlated to treatment success.
- Detailed Description
The purpose of the study was to carry out a pilot study on the short-term effect of intravitreal Bevacizumab (Avastin) injection on retinal blood-flow velocity and test whether the short-term haemodynamic changes could predict the longer term clinical result of the treatment.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
- Patients with CNV receiving Bevacizumab intravitreal injection
Exclusion Criteria
- Candidates in whom the retina could not be seen clearly because of media opacity or a poorly dilating pupil
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood flow velocity change 1 day following injection
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Tel aviv sourasky medical center
🇮🇱Tel aviv, Israel